Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
Crossref DOI link: https://doi.org/10.1007/s11060-016-2159-0
Published Online: 2016-06-09
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
von Bueren, André O.
Seidel, Clemens
Friedrich, Carsten
License valid from 2016-06-09